475 related articles for article (PubMed ID: 36710681)
1. A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
Huang Z
J Alzheimers Dis; 2023; 92(1):29-57. PubMed ID: 36710681
[TBL] [Abstract][Full Text] [Related]
2. Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
Huang Z
J Alzheimers Dis; 2024; 99(2):447-470. PubMed ID: 38669548
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous Association of Alzheimer's Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses.
Willén K; Sroka A; Takahashi RH; Gouras GK
J Alzheimers Dis; 2017; 60(2):511-524. PubMed ID: 28869466
[TBL] [Abstract][Full Text] [Related]
4. ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.
Volloch V; Rits-Volloch S
Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892224
[TBL] [Abstract][Full Text] [Related]
5. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
[TBL] [Abstract][Full Text] [Related]
7. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
de la Monte SM
Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
[TBL] [Abstract][Full Text] [Related]
8. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
[TBL] [Abstract][Full Text] [Related]
9. Detection of peri-synaptic amyloid-β pyroglutamate aggregates in early stages of Alzheimer's disease and in AβPP transgenic mice using a novel monoclonal antibody.
Mandler M; Rockenstein E; Ubhi K; Hansen L; Adame A; Michael S; Galasko D; Santic R; Mattner F; Masliah E
J Alzheimers Dis; 2012; 28(4):783-94. PubMed ID: 22064070
[TBL] [Abstract][Full Text] [Related]
10. The inside-out amyloid hypothesis and synapse pathology in Alzheimer's disease.
Gouras GK; Willén K; Faideau M
Neurodegener Dis; 2014; 13(2-3):142-6. PubMed ID: 24080821
[TBL] [Abstract][Full Text] [Related]
11. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
Jang YN; Jang H; Kim GH; Noh JE; Chang KA; Lee KJ
Neuropathol Appl Neurobiol; 2021 Aug; 47(5):625-639. PubMed ID: 33345400
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Alzheimer's Disease Amyloid-β Protein Precursor in Astrocytes Both in vitro and in vivo.
Liang Y; Raven F; Ward JF; Zhen S; Zhang S; Sun H; Miller SJ; Choi SH; Tanzi RE; Zhang C
J Alzheimers Dis; 2020; 76(3):1071-1082. PubMed ID: 32597805
[TBL] [Abstract][Full Text] [Related]
13. Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.
Zhan X; Jickling GC; Ander BP; Stamova B; Liu D; Kao PF; Zelin MA; Jin LW; DeCarli C; Sharp FR
J Alzheimers Dis; 2015; 44(4):1213-29. PubMed ID: 25697841
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
15. On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.
Volloch V; Rits-Volloch S
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474228
[TBL] [Abstract][Full Text] [Related]
16. Non-Fibrillar Oligomeric Amyloid-β within Synapses.
Pickett EK; Koffie RM; Wegmann S; Henstridge CM; Herrmann AG; Colom-Cadena M; Lleo A; Kay KR; Vaught M; Soberman R; Walsh DM; Hyman BT; Spires-Jones TL
J Alzheimers Dis; 2016 May; 53(3):787-800. PubMed ID: 27258414
[TBL] [Abstract][Full Text] [Related]
17. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
[TBL] [Abstract][Full Text] [Related]
18. I716F AβPP mutation associates with the deposition of oligomeric pyroglutamate amyloid-β and α-synucleinopathy with Lewy bodies.
Sieczkowski E; Milenkovic I; Venkataramani V; Giera R; Ströbel T; Höftberger R; Liberski PP; Auff E; Wirths O; Bayer TA; Kovacs GG
J Alzheimers Dis; 2015; 44(1):103-14. PubMed ID: 25182745
[TBL] [Abstract][Full Text] [Related]
19. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
[TBL] [Abstract][Full Text] [Related]
20. Synaptic Vesicle Protein 2B Negatively Regulates the Amyloidogenic Processing of AβPP as a Novel Interaction Partner of BACE1.
Miyamoto M; Kuzuya A; Noda Y; Ueda S; Asada-Utsugi M; Ito S; Fukusumi Y; Kawachi H; Takahashi R; Kinoshita A
J Alzheimers Dis; 2020; 75(1):173-185. PubMed ID: 32280101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
